Mode
Text Size
Log in / Sign up
N/A Completed N=116 Randomized Single-blind Prevention

Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities

Adolescent Behavior · Intellectual Disability · Down Syndrome · Physical Activity
Source: ClinicalTrials.gov NCT03684512 ↗
Enrolled (actual)
116
Serious AEs
2.6%
Results posted
Jul 2023
Primary outcomePrimary: Change in Adolescent Physical Activity From Baseline to 6 Months — -3.2; -0.6 minutes per day

Summary

The objective of this study is to compare the effect of two strategies to increase MVPA in adolescents with intellectual and developmental disabilities (IDD): a single level intervention delivered to the adolescent only, and a multi-level intervention delivered to both the adolescent and a parent .

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Adolescent Physical Activity From Baseline to 6 Months
-3.2; -0.6 —
SECONDARY
Change in Adolescent Moderate to Vigorous Physical Activity From Baseline to 18 Months
-1.5; 7.6 —
SECONDARY
Change in Parent Physical Activity
— —
SECONDARY
Change in Sedentary Time
— —
SECONDARY
Change in Parent Sedentary Time
— —
SECONDARY
Change in Cardiovascular Fitness
— —
SECONDARY
Change in Muscular Strength
— —
SECONDARY
Change in Motor Ability
— —
SECONDARY
Change in Quality of Life
— —

Eligibility Criteria

Inclusion Criteria

  • Mild to moderate IDD (IQ of 74-40).
  • Sufficient functional ability to understand directions, communicate preferences, wants, and needs through spoken language.
  • Living at home with a parent or guardian who is willing to participate in the intervention, with no plans to change this living situation and/or to leave the study area in the next 18 mos.
  • Wireless internet access in the home.

Exclusion Criteria

  • Unable to participate in moderate to vigorous physical activity (MVPA).
  • Pregnancy during the previous 6 mos., currently lactating, or planned pregnancy in the following 18 mos.
  • Unwilling to be randomized.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03684512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search